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There are three phases to the rheumatic attack:  first, a brief illness 
of respiratory infection with hemolytic streptococcus; second, a quies- 
cent interval of approximately 10  days; third,  the period of clinical 
manifestations of rheumatic fever.  The relationship of a  throat in- 
fection to the development of the rheumatic attack was described in 
the first paper of this series.  In each of the three groups being studied, 
nurses,  convalescent rheumatic patients  and  ambulatory rheumatic 
subjects, there was a well defined quiescent interval between the sub- 
sidence of the local infection and the onset of the rheumatic attack. 
The observations in 1930-31  illustrate these findings.  1  In the case of 
each student nurse, the quiescent period was at least 3 weeks; in the 
case  of  convalescent  rheumatic patients  at  The  Pelham  Home,  it 
varied from 5 to 27 days, with an average of 12 days; among the am- 
bulatory rheumatic subjects there was usually a similar lag; however, 
in a few instances severe rheumatic phenomena followed immediately 
after a "sore throat" subsided. 
The precise date of onset of rheumatism could not be judged with 
accuracy, and for this reason it has not been possible to determine the 
exact length of the quiescent interval.  In the case of certain severe 
local infections and of a  few tonsillectomies, almost immediate rheu- 
matic attacks were observed.  The usual finding was a definite period 
1 Haig-Brown  (1)  in 1886 and more recently Hector (2), Campbell and Warner 
(3)  and  Schlesinger (4) have also observed the constant occurrence of this quies- 
cent interval. 
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of quiescence, which varied from a few days to a few weeks.  The ob- 
servations in this study are adequately described by the words of Haig- 
Brown  (1)  written  nearly half  a  century ago:  "perhaps a  month, 
more commonly 10 days or simultaneously." 
Observations  in The Pelham Home 
Throat infections 
Apr.  21-22 
Mar.  1- 3 
Sept. 23-25 
Jan.  25-27 
Interval 
days 
14 
9 
5 
5 
Onset of 
rheumatic attack 
May  6 
Mar.  12 
Oct.  1 
Feb.  2 
Throat infections 
Feb.  22-25 
June 17-20 
Jan.  24-26 
Mar. 23-24 
Interval 
days 
8 
22 
10 
27 
Onset of 
rheumatic attack 
Mar.  6 
July  12 
Feb.  6 
Apr.  21 
Observations  on  Ambulatory Rheumatic Subjects 
Throat infections 
Feb.  21, 22, 23 
May 1 
Mar.  1, 2, 3, 4 
Feb.  4 
Jan.  27, 28 
"  15 
Feb.  12-16 
"  14-16 
Interval 
days 
10 
!  10 
l  8 
3 
7 
5 
17 
17 
Rheumatic 
attack 
May  10 
Mar. 12 
Feb.  7 
"  5 
Jan.  21 
Mar.  5 
"  3 
Throat infections 
Apr.  16-18 
Jan.  25 
Feb.  21-25 
Nov. 29 
"  1 
Jan.  18 
Feb.  22 
"  13 
Interval 
days 
8 
3 
12 
5 
14 
20 
10 
7 
Rheumatic 
attack 
l 
Apr.  27 
Jan.  28 
Mar.  9 
Dec.  3 
Nov. 14 
Feb.  7 
Mar.  2 
Feb.  20 
The occurrence of a  10 day period of quiescence between the sub- 
sidence of infection and the  onset of rheumatism suggests that the 
rheumatic attack begins when the immune response is at its height. 
This observation has led to the conception that the development of 
rheumatic fever may be associated with the immunity mechanism of 
certain individuals for handling products of hemolytic streptococcus. 
In order to investigate the immunological changes occurring in  the 
rheumatic subject between the subsidence of the local infection and the 
development of rheumatism, sera have been examined for the presence 
of antibodies  to  hemolytic streptococcus.  Four  types of  reactions 
were selected for investigation: agglutination; fixation of complement; 
occurrence  of  precipitins;  development  of  antistreptolysin.  The ALVIN  •.  COBURN  AND  RUTH  H.  PAULI  653 
methods employed and the findings for the 4 year period 1928-32  are 
as follows: 
A.  Agglutination  Reactions 
During the early part of this study the blood sera of a  number of 
acutely ill rheumatic patients were tested for the presence of agglutin- 
ins  to Streptococcus viridans.  Although agglutinins were present in 
high titer in patients with bacterial  endocarditis, there  was  no  in- 
stance in which this was true of the sera of patients with acute rheu- 
matism. 
The sera of five groups of individuals were tested for the presence of 
agglutinins to  hemolytic streptococcus against  strains  of hemolytic 
streptococcus: No.  C17  (rheumatic fever throat  strain),  hemolytic 
streptococcus Nos.  NY5  and 273  (scarlet fever strains).  The  sera 
tested  were  obtained  from  the  following  groups:  individuals  with 
proven hemolytic streptococcus infections  (scarlet  fever,  tonsillitis, 
erysipelas); acutely ill rheumatic patients;  quiescent rheumatic sub- 
jects; patients with lobar pneumonia; normal, healthy individuals as 
controls. 
The sera  ~ of the patients in the first two groups in most instances 
agglutinated one or all of the organisms to a  titer 1:10 to  1:40.  In 
a  few instances agglutination  occurred in  titer  1:80.  In  only one 
instance was agglutination observed in titer 1 : 160.  The sera of the 
pneumonia patients, quiescent rheumatic subjects and controls usually 
failed to agglutinate entirely or agglutinated to a titer no higher than 
1 : 40.  These tests demonstrated that the sera of acutely ill rheumatic 
subjects resemble in their agglutination titer the sera of patients re- 
covering  from  streptococcus  infection.  Because  of  their  low  titer 
this method of study was regarded as unsuitable. 
B.  Complement Fixation Reactions 
Complement fixation tests were performed with  three antigens  u 
hemolytic  streptococcus  carbohydrate,  scarlet  fever  streptococcus 
toxin,  scarlet  fever  streptococcus  nucleoprotein.  With  the  carbo- 
hydrate fractions and toxins no positive reactions were obtained, and 
these procedures were discontinued.  The protein fractions, however, 
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gave  reactions  and  were  made  up  in  the  following dilution  of milli- 
grams  of protein: 
1.  No. 273  --1:1,000; 1:10,000; 1:15,000; 1:20,000; 1:25,000; 1:50,000 
2.  "  C15DIII--I:I,000; 1:10,000; 1:15,000; 1:20,000; 1:25,000; 1:50,000 
3.  "  C17D  --1:1,000; 1:10,000; 1:15,000; 1:20,000; 1:25,000; 1:50,000 
The fractions  tested  showed great differences in their antigenic  strength.  Fraction 
C8D gave only negative reactions and Fraction C15DIII gave reactions only about one- 
fifth as strong as Fraction 273, of the same dilution.  This is illustrated  in the following 
table.  The reactions with Protein  273 were consistently  more intense  than those with 
C15D--illustrated  by two rheumatic patients, S and D. 
Dilutions of antigen.  1:10,000  1:20,000  1:40,000  1:50,000  1:100,000 
(C15D)..  +-4-++  -4-+ =~  --  --  -- 
(273).  ++++  ++++  +++  ++=~  ++ 
D (C~5D)...  ++++  +  -  -  - 
D (273) .............  ++-4-+  ++-4-  -4-+  --  -- 
The technique employed for these tests was the method customarily employed 
in the Wassermann reactions.  The tubes together with a positive and negative 
serum control as well as antigen controls consisting of 0.4, 0.3, 0.2, 0.1 cc. amounts 
were water bathed at 37.5°C.  for 1 hour, after which each tube received 0.2 cc. of 
sensitized  5 per cent sheep cells  and was again incubated at 37.5°C.  Readings 
were made as soon as the antigen and serum controls cleared and were interpreted 
as follows: 
Human serum  reactions  0.02 cc.  0.0! cc. 
+++'4-  No  hemolysis  No  hemolysis 
-4- +  A-  ....  Slight  " 
++  ....  Complete  " 
-4-  Slight  "  "  " 
Negative  Complete  "  "  " 
The  patients  whose  sera  were  tested  included  a  control  group  be- 
lieved  to be non-rheumatic;  a  control group of student  nurses,  some 
known  to  be in  good health,  others  known  to have  acute  hemolytic 
streptococcus  pharyngitis;  rheumatic  subjects  believed  to  be  quies- 
cent,  and patients  with  acute  rheumatic  fever.  The  determinations 
are  recorded in Table  I. TABLE  I 
Complement Fixation Reactions 
Antigen Nucleoprotein C15DIII 
Dilutlons of  antigen ..........  I 1:1,00o [1:10,00o[1:15,000  1:20,000  1:25,000[1:30,00011:35,000  1:40,000 
Control group,  non-rheumatle; spring months 
Be  ........................ 
Bo  ........................ 
G  ......................... 
P  .........................  I 
Nurses, normal and recovering from hemolytic streptococcus pharyngitis; spring months 
Br., normal 
• +  +  + 
L.  "  . ...............  i ++ 
S,  ~  ................ 
C.,* pharyngitis ..............  +  ++-}-  ~+-b+  +-b 
T.*  ~L  ............ 
H.  "  ............  ++  - 
++  + 
Rheumatic subjects clinically quiescent; spring monthst 
Fi ..........................  -- 
C  ........................ 
Fat ......................  ++++ 
W.H  .......................  -- 
V(a  ........................  -- 
V~  r .........................  -- 
La  ........................  -- 
Kn  ........................ 
+++  +++  + 
Active rheumatism; spring months 
Ma  ......................... 
Gi  ......................... 
Oa; ....................... 
Fe  ........................ 
Fa  ........................ 
Pa  ........................ 
T  ......................... 
Br  ........................ 
H  ......................... 
+ 
+++  + 
++++  _ 
++++ 
+ 
+ 
+ 
-[ 
* C and T  had scarlet fever,  t  Serum examined during the fallshowed no strong reactions. 
As  is  indicated  in  Table  I,  the  complement  fixation  reaction 
appeared  extremely  sensitive  for  the  determination  of  anti- 
body.  Because  of  the variability in hemolytic  systems  the method 
was not  found satisfactory  for  sharp  interpretation.  In  certain  in- 
stances,  the  strongest  reactions were  detected  among rheumatic pa- 
tients  clinically quiescent;  while in fulminating attacks  the  reaction 
was frequently less striking.  The sera of non-rheumatic individuals 
infected by hemolytic streptococcus gave a positive fixation at a dilu- 
tion 1 : 1,000 in most instances, and the serum of each acutely ill rheu- 
matic  subject gave  a  positive  complement fixation in  1:10,000  dilu- 
tion of the antigen.  This type of immunity response suggests a recent 
infection with Streptococcus hemolyticus. 
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The results of the complement fixation tests are as follows: The ma- 
jority of the control sera were negative.  The sera of individuals con- 
valescing from sore throat or scarlet fever were positive.  The sera of 
some rheumatic  subjects without clinical symptoms showed strongly 
positive reactions in the spring.  The  sera of all  rheumatic  subjects 
during  the attack showed a  positive reaction,  but in  some instances 
this reaction was not so strong as in the sera of individuals who were 
symptom-free. 
C.  Precipitin Reactions 
To  investigate  further  the  possible relationship  of the  rheumatic 
attack to infection with Streptococcus  hemolyticus,  the occurrence  of 
precipitins  to hemolytic streptococcus fractions has been  studied  in 
detail over a long period of time.  That these reactions are not entirely 
specific has been demonstrated  by the work of Lancefield  (5)  which 
indicates an antigenic relationship of the proteins of streptococcus to 
those  of pneumococcus,  staphylococcus and  other  organisms. 
The  materials  used  as  precipitinogen  consisted  of  the  following 
hemolytic  streptococcus  substances:  toxins,  carbohydrates  and  pro- 
teins.  The  toxins were tested  for precipitation  in  several dilutions 
and the carbohydrate fraction in concentrations  1:25,000,  1: 100,000, 
and  1:500,000.  Reactions with the former were uniformly negative 
and  with  the  latter  rarely  positive.  Their  use  was  discontinued. 
The  protein  fractions  of  Streptococcus  273  previously used  in  skin 
testing  (6) 3 and protein  fractions  recently prepared  by Dr.  Michael 
Heidelberger (7) have been employed throughout the study.  The  D 
fractions were obtained after acidification of the cells at pH 6.5.  The 
K  fractions and 273 were obtained at pH 11 to 13 after removal of the 
fractions  between pH 6.5  and pH  11.  In  general  the  dilution  used 
was milligrams of protein 1 : 2,000. 
The technique of precipitin tests was as follows: To 0.2 cc. each of fresh human 
sera, was added an equal quantity of nucleoprotein fraction.  (It is essential to 
have both clear sera and protein solutions.)  After  mixture each tube  was im- 
mediately and thoroughly shaken.  Readings were taken at various intervals, the 
first after 20 m~nutes at room temperature,  the second after  2 hours in  37.5°C. 
water and the third after overnight refrigeration. 
The development of precipitins was first studied among a class of 50 
student nurses.  The antigen used was hemolytic streptococcus Frac- 
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tion  C15D,  dilution  1:2,000.  In  September,  1930,  all  of  the  indi- 
viduals were tested for the presence  of precipitins in their blood and 
none were found.  During the spring months the sera of the same indi- 
viduals were again tested, and the results are summarized in Table II. 
TABLE  II 
A Study of Precipitin Reactions to Hemolytic Streptococcus  Fractions among a Class 
of 50 Nurses 
Patient 
Group A 
B  .....................  Normal health 
L .....................  "  " 
Group B 
S .....................  ( 
W ....................  ( 
H,* ................... 
Bix  .................... 
Bil  .................... 
F ..................... 
Group C 
T...  ~  Normal  health 
.................  [  Scarlet fever 
C  ......  ~  Normal  health 
.............. [  Scarlet fever 
Group D 
Cr ...................  { 
Me ...................  { 
Snl ...................  • 
Condition  Fall, 1930  Spring, 1931 
Normal health 
*Hemolytic Streptococcus  plmryngltls 
Normal health 
Hemolytic Streptococcus p~r~gigs 
Normal health 
Acute hemolytic streptococcus  infection fol- 
lowed by rheumatic fever 
Normal health 
tAcute hemolytic streptococcus  infection fol- 
lowed by rheumatic fever 
Normal health 
Acute hemolytic  streptococcus  infection fol- 
lowed by rheumatic fever 
+  +±  +++ 
-  +  + 
+  +~  +++ 
+  +~  +++ 
These readings are expressed: one, immediately, second  at  2  hours at 37°C. and  the 
last, overnight in  ice box.  They represent uncentrifuged  findings.  -b-t-q-q-  =  com- 
plete disc  at  bottom of tube with clear supernatant,  q-q-q-  =  flocculated  sediment. 
q-q-  =  no  sediment;  granules or  floccules in  suspension,  q-  =  clouding  with  whirl. 
±  =  clouding with no whirl. 
Intermediate readings were also made, such as,  +-[--[-4- =  incomplete disc.  -}-+4- 
-- flocculated sediment with some large floccules still in suspension.  +4-  =  few granules 
or floccules in suspension with slight clouding of supernatant. 
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From Table II, it is seen that Group A escaped infection and their 
sera remained negative for precipitins; Group B developed hemolytic 
streptococcus pharyngitis and precipitins appeared in some instances 
during convalescence; Group C  contracted scarlet fever and precipi- 
tins were not detected during the acute stage of the illness; Group D 
contracted hemolytic streptococcus pharyngitis and developed rheu- 
matic  fever.  The  appearance  of  precipitins  to  hemolytic strepto- 
coccus protein fractions in their sera was striking. 
A second study was made to determine the relationship of the de- 
velopment of precipitins for hemolytic streptococcus fractions to ac- 
tivity of the process in rheumatic subjects.  At the end of the sum- 
mer,  the  rheumatic  process  appeared  quiescent  in  nearly  every 
individual.  During the early fall, two of the group contracted pharyn- 
gitis and  developed severe rheumatic attacks.  In  the  late  winter 
months,  most  of  the  patients  were probably  exposed to  infection. 
Some escaped symptoms of upper respiratory disease and the rheumatic 
process  appeared  quiescent.  Others  contracted  throat  infections. 
Most of these developed severe rheumatic attacks; a few appeared to 
escape.  With the exception of these few individuals,  the results of 
the precipitin tests are presented in Table III. 
From Table III it is seen that in the sera of quiescent rheumatic 
subjects precipitins were not detected in the fall.  Sera from the same 
individuals, clinically quiescent in the spring, gave in most instances 
negative or weakly positive reactions.  In contrast, the sera of rheu- 
matic patients acutely ill in the fall or in the spring months in almost 
each instance gave a  strong precipitin reaction to protein fractions of 
hemolytic streptococcus.  This occurred only in the individuals who 
developed acute rheumatism.  It was pointed out in the first paper of 
this series that in certain instances following hemolytic streptococcus 
infection the rheumatic subject escapes a definite attack.  The sera of 
these patients have been studied at frequent intervals during the 4 
weeks following infection.  In none were precipitins detectable. 
In order to correlate the clinical signs of activity of the disease proc- 
ess with the content of precipitins to fractions of hemolytic streptococ- 
cus in  the sera of rheumatic subjects,  a  few individuals  have  been 
studied  closely.  Patient  Ker.  during a  severe rheumatic attack in 
December,  1930,  had  strong  precipitins  in  her  serum.  These  dis- ALVIN F. COBURN  AND  RUTH  H. PAULI  659 
appeared  with  clinical  improvement and  reappeared  again  during 
another intense recrudescence.  Individual Kor. with a  fulminating 
rheumatic attack in November, 1930, likewise showed a high concen- 
tration of precipitins.  Signs of mild rheumatic activity persisted in 
TABLE III 
A  Study of the Relationship of the Precipitin Reaction to Quiescence and Activity of 
the Rheumatic Process 
Patient 
Fall,  1930  Spring,  1931 
273  [  C15D  273  [  CISD 
Group  A--apparently quiescent 
C  ................................. 
H  ................................ 
Ki  ................................ 
La  ................................ 
Lu  ............................... 
MR .............................. 
Ru  .............................. 
W&  .............................. 
W~ ............................... 
Fa  ............................... 
--+ 
-~+ 
~=  ÷  +++ 
-  +  .j.=~= 
÷÷ 
_  _  ÷++ 
+ 
_  ~=  ÷+ 
--  v=  ÷ 
±  +  +++ 
Group B--active rheumatism 
Ker  ............................... 
](or  .............................. 
Kel.*  ............................. 
Cl.t .............................. 
Fa  ................................ 
Br ................................ 
T  ................................. 
O  ................................. 
P  ................................. 
S ................................. 
F  ................................. 
G  ................................. 
GR ................................ 
Gi ................................ 
+  ÷+  +++ 
+÷  + 
=~,÷+ 
++~= 
-±+ 
~=  a=  .j. 
-++÷ 
~=  :~=  =~ 
--  =e  ÷ 
++÷+ 
~=  +  +÷ 
~=  ÷  +++ 
-÷  ÷ 
~=  ÷  ++÷ 
+  +  +++ 
÷  ~=  a= 
-÷  ,÷~= 
+  +=~  +++ 
* Negative 1 month before attack,  t  Negative 4 months before attack. 
this patient for 6 months.  The precipitins did not disappear during 
this period, increased during a  slight recrudescence in March,  1931, 
and finally were no longer detectable when the disease seemed quies- 
cent.  These findings are presented in Table IV, a. 
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TABLE  IV~  a 
Changes in the Precipitin Reaction with Fluctuations in Activity  of the Rheumatic 
Process 
Patient 
C'L 
++ 
Protein fraction, dilution 1 : 2,000 
C8D 
g$~. 
During attack, Nov., 1930  .............. 
During convalescence, Jan., 1931  ........ 
Feb., 1931  ............................ 
During recrudescence, Apr., 1931  ........ 
During attack, May, 1931  .............. 
During quiescence, Feb., 1932 .......... 
Kor. 
During attack, Nov. 1, 1930 ............  ++  +  -- 
Nov. 30, 1930 ........................ 
During convalescence, Dec., 1930 ....... 
During slight flare up, Mar., 1931 ....... 
During quiescence, Feb., 1932 .......... 
+  ++  +  ++ 
++  +  - 
(-) 
--  --  --(--)* 
273 
-  +  +++ 
_  _  -(-) 
+  +  +++ 
--  --  -4- 
-(-) 
C15D 
fib 
=~++ 
_  _  -(+) 
-++=~ 
-(-) 
* In addition  to the customary  readings made  immediately,  after 2  hours' incubation 
and  after standing  overnight  in  the  ice  box,  a  fourth  determination  has  been  recorded 
when indicated.  This is expressed in parentheses and represents the findings after 10 min- 
utes' centrifugalization at moderate speed. 
TABLE  IV,  b 
Changes in, the Precipltin Reaction in Relation to the Clinical Course of the Rheumatic 
Attack 
Patient 
Dec. 3 
Maz. 
Condition  ..........................  Sick 
Reactions to  1 : 2,000 dilution of Frac- 
tion C17D ........................ 
Fraction C17K  ...................... 
Condition  ......................... 
Reactions to 1 : 2,000 dilution of Frac- 
tion C17D ....................... 
Fraction C17E  ..................... 
+ 
+ 
Jan.  3 
Sick 
fi(+)* 
+(++) 
Date 
)ec. 24 
Sick 
+ 
+ 
Jan.  6 
Sick 
-C+) 
+(+) 
Dec. 28  Jan.  4 
Verysick  Sick 
Jan.  10  Jan. 15 
Very sick 
+(++) 
+(+++) 
Jan.  11  [  [  ~'19" 
l 
[ 
Recovering 
Mori- 
bund 
+fi 
Feb. 
9 
=1= 
* Parentheses  indicate  readings after  centrifugation,  single  determinations  represent 
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precipitins during acute rheumatism, absence during recovery and re- 
appearance during recrudescence, the sera of other individuals were ex- 
amined at frequent intervals during a single, severe attack of rheumatic 
fever.  The findings in two of these  are  presented  in  Table  IV,  b. 
Patient Maz.  experienced a  fulminating  rheumatic  attack  and re- 
covered; Patient Man. died 3 weeks after the onset of intense rheuma- 
tism. 
TABLE  V 
A  Study o/t~ Precipitin Reaction to Streptococcus Protein Fractions 
Patient  273  CISD 
Scarlet fever 
Br  ........................................................ 
R .......................................................... 
H .......................................................... 
I ........................................................... 
+++ 
--  :lz  - 
+q-q- 
Lobar  pneumonia (pneumococeus) 
W,-Pn. IV ................................................. 
B.-Pn. nI ................................................. 
Bo.-Pn.  n  ................................................. 
Gi.-Pn. IV ................................................. 
Sh.-Pn. IV ................................................. 
--++ 
-  -  dffi 
-++ 
-++ 
_  _  =~= 
_  _  + 
Erysipelas  and  mastoiditis 
T ..........................................................  I  --+  I  --+ 
* Mc. developed rheumatic heart disease. 
From Table IV, b, it is seen that with recovery, the precipitin con- 
tent diminished in the serum of Patient Maz.  In contrast, the con- 
tent  of  precipitins  to  hemolytic  streptococcus  protein  fraction  in- 
creased in  the  serum of Patient  Man.  to the day of death.  These 
were both  examples of intense  rheumatism.  In the less  severe at- 
tacks, the precipitin content of the sera has been found to change more 
rapidly,  remaining at a  high level for only a  few days.  There is  a 
close parallelism between intensity of the rheumatic process and the 
strength of the precipitin reactions. 
For purposes of comparison,  a  study was made of the content of 
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tions.  Determinations were made during the course of lobar pneu- 
monia, during the 3rd week of scarlet fever and during recovery from 
erysipelas.  The findings are presented in Table V. 
From Table V it is seen that weak precipitin reactions occurred in 
the sera of patients with respiratory infections.  The only strong per- 
TABLE  VI~  a 
Precipitin Reactions to Hemolytic Streptococcus  Fractions in Quiescent Rheumatic 
Subjects Inoculated with T.A.B.  Vaccine 
I 
Patient  Fraction  273  ]  Fraction  17D  I  Fraction  17K  Control 
Before  vaccination  with B. lyphosus  and  paratyphosus  A  and  B 
Br  ............................  --  --  --  (-) 
m y ............  iiiiiiiiiiiiiill  -  -  -  ~-~ 
Mo  ...........................  -  --  -  (-) 
~i  ;iiiiiiiii  ...................  ~-~ 
M  ............................  --  --  --  (--) 
_  _  _  (-) 
_  _  _  (+++) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (+) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
-  -  -  C-) 
_  _  _  (-) 
_  _  _  (-) 
1 and  3  wks.  after  vaccination 
Br ............................  --  --  --  (--) 
~Y  ............  ii:iiiiiiiiiiiii  -  -  -  (-~ 
:!i.i i! iiii!i  i ! i!i!! 
~i";il;iiiill  ...................  <-~ 
M  --  --  --  (-) 
_  _  _  (--) 
_  _  _  (-) 
_  _  _  (+±) 
_  _  _  (+~) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  ~  (+) 
_  _  _  ~-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  +(-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
_  _  _  (-) 
TABLE  VI,  b 
Precipitin Reactions in a Rheumatic Subject with Pneumococcus Type II 
Pneumonia 
Fraction  17D  Fraction  17K  Control  PaEent  Cr. 
1.  Before  Nor.  l,  1930  ...........................  ]  --  --  -  (~) 
2.  Onset  Jan.  22,  1932  ............................  I  --  --  ±  (+) 
3.  DuxingJan.  27,  1932  ..........................  ]  -  -  +  (+~) 
4.  Convalescence  Feb.  8,  1932  .....................  ]  --  --  ± 
5.  Recovery  Feb.  22,  1932,  4  wks.  after  onset  .......  ]  --  --  --  (=~) 
_  _  _  (±) 
_  _  _  (±) 
_  _  +  (~) 
_  _  _  (-) 
_  _  _  (±) 
_  _  _  (~) 
_  _  _  (-) 
sistent precipitin reaction among these patients was in an individual 
with scarlet fever which terminated in rheumatic heart disease. 
As a control measure, studies were made to determine the influence 
of a  reaction to heterologous bacterial proteins on the formation of 
precipitins to hemolytic streptococcus products.  First, ten quiescent ALVIN  •.  COBURN  AND  RUTH  H.  PAIYLI  663 
rheumatic patients, who were under close observation at The Pelham 
Home, were given one subcutaneous dose of T.A.B.  vaccine  (B.  ty- 
phosus 1 billion, Para A and Para B ½ billion each).  This was followed 
by a  sharp reaction in almost each instance.  The sera were tested 
before inoculation, and at the end of 1 and 3 weeks.  Second, a  few 
rheumatic subjects contracted pneumococcus lobar pneumonia.  Their 
sera were tested during the disease and in convalescence.  The find- 
ings are presented in Tables VI, a, and VI, b. 
As shown in Tables VI,  a,  and V,  b, the precipitin content of the 
sera was not influenced by a non-specific reaction.  A few rheumatic 
subjects with pneumonia showed the presence of weak precipitins dur- 
ing pneumococcus infection and their disappearance in convalescence. 
Summary of Precipitin Tests 
The results may be summarized as follows: 
In the sera of 150 apparently healthy rheumatic subjects in the fall 
of 1930, only two individuals were found to have precipitins for hemo- 
lytic streptococcus protein fractions.  In the sera of 50 healthy stu- 
dent nurses entering training in the fall of 1930, no precipitins were 
detected.  In the sera of patients with lobar pneumonia, the formation 
of precipitins to hemolytic streptococcus fractions was slight, definite 
but not persistent.  In the sera of twenty patients during the acute 
stages  and  convalescence from  scarlet  fever or  erysipelas,  marked 
precipitin  formation was  detected in  one individual.  She  was  the 
member of a rheumatic family and developed rheumatic carditis.  In 
the sera of twenty student nurses who contracted hemolytic strepto- 
coccus throat infections in  the spring of  1931, precipitins were not 
detected during the acute illness but appeared 4 weeks later in slight 
concentration in most individuals.  In four instances the appearance 
of precipitins was marked; three of these individuals developed rheu- 
matic fever.  In the sera of ten rheumatic subjects given prophylactic 
vaccination with typhoid and paratyphoid vaccine, there was no de- 
velopment of precipitins to the protein fractions of hemolytic strepto- 
coccus.  One rheumatic subject who contracted Pneumococcus Type 
II pneumonia developed precipitins to protein fractions of a  strepto- 
coccus but they disappeared with complete resolution in the lung and 
did not reappear within 4  weeks.  In the sera of ten patients with 664  STEEP.  HEMOLYTICUS  AND  RHEIYMATIC  FEVER.  III 
acute rheumatism in  the fall months of  1930  and 1931,  precipitins 
were detected in each serum.  4  In the sera of 50 patients with fulmi- 
nating rheumatism in the spring months of 1928-31, precipitins were 
detected in  all  except two instances.  In  the sera of six  rheumatic 
subjects who appeared to escape attacks following hemolytic strepto- 
coccus infection, precipitins were not detected.  In the sera of rheu- 
matic subjects without demonstrable precipitins in the fall of 1930, 
fourteen manifested rheumatic attacks in the spring and all developed 
precipitins.  Of thirty whose disease appeared to  remain  quiescent 
in  the spring,  five developed precipitins.  This was marked in only 
one instance.  In the sera of ten individuals with acute rheumatism, 
the concentration of precipitins became more marked as the activity 
of the process heightened.  With subsidence, precipitins disappeared. 
They returned during recrudescence.  In one fatal, fulminating attack 
which perhaps  represented the onset of the disease in  a  rheumatic 
baby, the precipitin titer rose during the fortnight's illness and was 
marked on the day of death. 
D.  The Development of Antistreptolysin 
Through the kindness of Dr. E. W: Todd of The Belmont Labora- 
tories,  Sutton,  England,  the  development of another  antibody has 
been studied in the patients described in the first paper of this series. 
While working with streptococcal hemolysin, Todd (9) observed that 
antihemolysin  was  not  formed  in  animals  immunized  to  Klebs- 
I~ffter bacillus, pneumococcus, hemolytic staphylococcus, non-hemo- 
lytic streptococcus or  other infectious  agents,  but  only in  animals 
immunized  to  Streptococcus  hemolyticus.  In  conjunction  with  Dr. 
Todd,  the antihemolysin titers of the sera previously examined for 
precipitins have been determined.  Some of these findings are being 
reported elsewhere (10)  in  units  of  antihemolysin.  In  the  present 
paper,  the antistreptolysin titers are recorded as the volume of the 
patient's serum required to neutralize 2½ minimal hemolytic doses of 
yeast extract streptolysin (M.H.D.).  The titers are therefore expressed 
as  fractions  of  1.0  cc.,  and  N.I).  is  used  to  designate neutralizing 
* These sera were tested with pneumococcus "C"  substance.  Positive reac- 
tions were obtained only during the febrile period.  This phenomenon was iden- 
tical with that previously described  by Tfllett and Francis (8). ALVIN  F.  COBLrRN  AND  RUTH  H. PAULI  665 
dose.  The  serum  of Patient  Ker.  is  used  as  a  control  throughout 
the  present  study. 
The sera of three groups of non-rheumatic subjects were tested first.  ~ 
These consisted of normal individuals in good health; patients conva- 
lescing from hemolytic staphylococcus or tuberculous bone infections, 
and  individuals  recovering  from  hemolytic  streptococcus  infection. 
The findings are presented in Table VII. 
TABLE  VII 
A  Study of the Antistreptolysin  Content of Sera from Rheumatic Subjects 
A.  Normal individuals 
whii Good  e,t  Wo...  "  '~ 
Ha...  "  " 
To...  ¢'  ** 
cc. 
S.D.  =  0.05 
"  =  0.05 
"  =  0.02 
"  =  0.t 
"  =  0.3 
"  =  0.01 
W& .... 
Do ..... 
Mo .....  I°i::::: 
Good health 
a  lc 
cc. 
•.D.  =  0.02 
"  =  0.02 
"  =  0.02 
"  =  0.02 
"  =  0.02 
B.  Patients  convalescing from infections other  than  hemolytic  streptococcus 
f 
Gr  ......  [  Osteomyelitls 
Sh  ......  " 
Go ......  Hemolytic  staphylococcus 
abscess 
Ca .....  Tuberculosis of hip 
c¢. 
N.D. =  0.03 
"  =  0.02 
"  =  0.02  I!i  ** 
Ga .....  Tuberculosis of hip  ~.D.  =  0.02 
Ba .....  Poliomyelitis  "  =  0.07 
i~ .....  Psoas abscess  =  0.02 
Pe'"  "'.....  Tuberculous spine  =  0.02 
"  "  =  0.009  "  =  0.02 
"  ffi 0.02 
C.  Patients convalescing from hemolytic streptococcus  infections 
Ca .....  Scarlet fever,*  1st  wk.  ~.n.  =  0.01  In .....  I  Scarlet fever, 3rd wk.  N.D.  ~c0.004 
~o .....  "  "  Xst  ....  = 0.006 IItMc  ....  /  ....  4th  "  =  0.005 
~r ......  "  "  3~d  ....  -- 0.O06 I  m  .....  /  ....  8th  "  = 0.OO3 
Hi ......  "  "  3rd  "  "  0.006  Tu .....  [  Erysipelas,  3rd  "  =  0.0008 
* These sera were obtained through the kindness of the Willard Parker Hospital. 
t Mc. developed  rheumatic fever. 
Table VII shows that the sera of individuals and patients with tu- 
berculous or hemolytic staphylococcus infection had a  low content of 
antistreptolysin.  In  contrast,  the  serum of patients with hemolytic 
streptococcus  infection was high  in  almost  each instance. 
6 All of these antistreptolysin determinations were made by Dr. E.  W.  Todd, 
Belmont  Laboratories, Sutton,  Surrey, England.  Through his generosity  they 
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A second series of observations was made on a group of normal stu- 
dent nurses to observe the effect of streptococcus infections on the 
antistreptolysin titer.  On admission to the Training School in Sep- 
tember,  1930, while apparently free of hemolytic streptococcus and 
in good health, their sera showed a  normal titer  (except in two in- 
stances).  During the month of April, 1931, sera were again obtained. 
The individuals were divided into three groups: those exposed to in- 
fection but in good health; those acutely ill with scarlet fever; those 
TABLE  VIII 
The Influence of Hemolytic Streptococcus Infection  on the Antistreptolysin  riter of 
Student  Nurses  under  Close Observation Clinically  and Bacteriologically 
Apr.,  1931 
Group A.  In good health but exposed to infection 
cc. 
Patient L ..............................................................  N.D.  =  0.02 
"  B ..............................................................  "  =  0.03 
"  S ...............................................................  "  =  0.02 
Group B.  At onset of scarlatina 
i  co.  Patient T ..............................................................  ~.v.  =  0.07 
"  C..  "  =  0.02 
Group C.  During convalescence from hemolytic streptococcus tonsillitis 
Patient Fan  ............................................................  N.D.  ~C0.007 
"  B  ..............................................................  "  ffi 0.003 
"  H  ..............................................................  "  =  0.005 
"  S ...............................................................  "  =  0.007 
convalescing from hemolytic streptococcus pharyngitis.  The results 
are summarized in Table vnI. 
Group A, the individuals who remained in good health, although 
exposed to infection, showed no change in titer;  Group B, the indi- 
viduals  acutely  ill  with  hemolytic streptococcus  throat  infections, 
showed no change in titer; Group C, the individuals convalescing from 
hemolytic streptococcus throat infections, showed a  marked rise in 
antistreptolysin content.  These determinations indicate that  there 
occurs normally a rise in antistreptolysin content of the serum during 
convalescence from hemolytic streptococcus infection. ALVIN  F.  COBURN  AND  RUTH  H.  PAULI  667 
For purposes of control, two studies were made to test the effect of 
non-specific  stimulation with a heterologous antigen.  First, the sera 
of ten children convalescing from rheumatic fever were tested before 
and after T.A.B.  subcutaneous inoculation.  Second, the serum of a 
patient with rheumatic heart disease was tested before, during and 
after Pneumococcus Type II pneumonia.  The results are presented 
in Tables IX, a, and IX, b. 
TABLE  IX,  a 
A ntistreptolysin  Titers of Convalescent Rheumatic Patients before and 1 and 3 Weeks 
after Typhoid  Vaccination 
Patient 
Br... 
[~y  ....... 
~u.,. 
[-Ig.* ..... 
N.D. 
Be- 
fore 
cc. 
0.009 
0.02 
0.02 
0.02 
0.01 
1 wk. 
after 
cc. 
0.009 
0.02 
0.02 
0.02 
0.01 
3 wks. 
after 
cc. 
0.02 
Patient 
Kr... 
]~].e ....... 
Mo  ....... 
Po  ............. 
Ra  ......... 
N.D° 
~c 
Bc- 
fore 
~c. 
0.006 
0.009 
0.004 
0.02 
0.008 
1 wk.  3 wk~ 
after  after 
cc.  cc. 
0.00~ 
0.00~ 
0.02  0.03 
0.02  0.02 
0.00~  0.01 
* Ha.  contracted  hemolytic  streptococcus  pharyngitis  8  weeks  later  and  in  the  2nd 
week  the  N.Y.  rose  to  0.008  cc. 
TABLE  IX,  b 
Antistreptolysin  Titers in a Rheumatic  Subject with Pneumococcus  Type II 
Pneumonia 
CC. 
Patient Ch.  Before  pneumonia  ~.v. -  0.004 
Onset of  "  "  =  0.006 
During  "  "  ffi 0.007 
Convalescing from pneumonia  "  =  0.008 
Table IX, a,  shows  that inoculation with T.A.B. vaccine did not 
increase the titer of aatistreptolysin.  The fall in  titer of Patients 
Mo.,  Br.  and Ra.  is unexplained.  Table IX,  b,  shows  that during 
Pneumococcus Type II infection the antistreptolysin titer of a rheu- 
matic subject did not rise but tended to fall to normal. 
Because of the constant development  of a high fiter of antistreptoly- 
sin in individuals convalescing from infection with hemolytic strepto- 
coccus, a study was made of the content of this antibody in the sera of 
patients who, while under observation, contracted hemolytic strepto- 668  STREP.  HEMOLYTICUS  AND  RHEUMATIC  FEVER.  III 
coccus  infection  and  developed  rheumatic  fever.  The  individuals 
under investigation included children and adults.  The sera were ob- 
tained  during  the  1st week of typical  attacks  of acute  rheumatism. 
The findings are presented in Table X. 
TABLE  X 
A  Study  of the Antistreptolysin  Content of Sera from  Patients  Developing Acute 
Rheumatism while Convalescing  from Respiratory Infection with Hemolytic 
Streptococcu,~ 
Patient 
Acute  rheumatic  fever 
¢¢. 
N.D.  =  0.007 
"  =  0.003 
"  =  0.007 
"  =  0.007 
"  =  0.004 
Patient 
Ro  ........ 
Ri ........ 
O ......... 
Sh  ........ 
Acute  rheumatic  fever 
,  ,  cc 
¢6. 
~.D.  =  0.00~ 
"  =  0.00~ 
"  =  0.002 
"  =  0.00~ 
"  =  0.004 
Table X  shows the constantly high titer of antistreptolysin  in  the 
sera of patients with acute rheumatism following hemolytic streptococ- 
cus pharyngitis. 
TABLE  XI 
Antistreptolysin Titer of Patients Admitted to the Presbyterian Hospital Wards with 
Acute Rheumatic Fever  from Spring, 1928, to Fall, 1931, and without Hemolytic 
Streptococcus in the Throat Flora 
Patient 
K  ..... l 
M  ..... 
E, 
E  ...... 
s 
s 
L.. 
C... 
Ch.. 
Ch.. 
P  ....... 
Acute  rheumatic  fever 
,  cc  ¢c 
,  cc  , 
~,  cc  , 
C¢. 
I~'.D.  =  0.002 
"  =  0.004 
"  =  0.004 
"  =  0.003 
"  =  0.003 
"  =  0.002 
"  =  0.009 
"  =  0.002 
"  =  0.003 
"  =  0.004 
"  =  0.003 
"  =  0.003 
Patient 
P  ......  i 
Co.. 
Co... 
B .... 
Cr.. 
D  .... 
L. 
R  .... 
Sh.., 
G 
Acute  rheumatic  fever 
u  Lc  u 
C6. 
I~.D.  =  0.003 
"  =  0.006 
"  =  0.00~ 
"  =  0.008 
"  =  0.006 
"  =  0.006 
"  =  0.004 
"  =  0.005 
"  =  0.004 
"  =  0.006 
"  =  0.00~ 
Another series of observations were made on patients admitted  to 
the  Presbyterian  Hospital  with  acute  rheumatic  fever  and  without ALVIN  F.  COBURN  AND  RUTH  H.  PAULI  669 
hemolytic streptococcus in the throat flora.  The group included chil- 
dren and adults, in various seasons, between  1928 and  1931.  The 
findings are presented in Table XI. 
The determinations show that the sera of patients admitted to the 
hospital with acute rheumatic fever following respiratory infection had, 
irrespective of the bacteriology of the throat flora, a high titer of anti- 
streptolysin. 
A  third series of determinations were made on the sera of patients 
with acute rheumatism who denied a preceding respiratory infection. 
The findings are presented in Table XII. 
From Table XII it is seen that the sera of these individuals, like 
those of the patients known to  have a  respiratory infection prelimi- 
TABLE  XII 
Antistreptolysin  Titer of Patients with Acute Rheumatic Fever Who Denied 
Preceding Respiratory Infection 
Patient  Patient 
CO° 
F ...........  Acute rheumatic fever:  N.D.  =  0.003  Dev  ........  Acute  rheumatic fever 
K ....  "  "  "  "  =  0.002  R  ....  "  "  " 
FI  ....  "  "  "  "  =  0.008  N  .....  "  "  " 
Dem...  "  "  "  "  =  0.002 
CC. 
N.D.  =  0.002 
"  =  0.002 
"  =  0.002 
nary to the rheumatic attack, contained a high titer of antistreptoly- 
sin.  This was approximately the same as appears in convalescence 
from hemolytic streptococcus infection. 
For purpose of comparison, a  study was made of the antistreptoly- 
sin content of the sera of rheumatic subjects whose disease process ap- 
peared to be quiescent.  The findings are presented in Table XIII. 
Table XIII  shows that in the majority of sera studied,  the anti- 
streptolysin content was normal.  In a  minority, the titer was ele- 
vated, but not to the same degree as observed in most patients with 
acute rheumatism. 
During the acute rheumatic attack,  the antistreptolysin titer was 
found to be high, and during inactivity of the disease process it ap- 
peared normal in most instances.  To trace the changes in the anti- 
streptolysin titer of rheumatic subjects, sera were examined at inter- 670  STREP.  ttEMOLYTICUS  AND  RHEUMATIC  :FEVER.  III 
TABLE  XIII 
A ntistreptolysin  Titer of Apparently Quiescent Rheumatic Subjects from Spring, 
1928, to Fall, 1931 
Patient 
Mul  ....  Jan.  14,  1932 
Gill  ....  "  14, 1932 
[. Jo ....  "  14,  1932 
]'. Jo ....  Oct.  8,  1930 
Co .....  June  10,  1931 
Cou ....  Jan.  14,  1931 
fin  .....  Dec.  11,  1931 
gore  ....  Jan.  7, 1932 
FI  ......  "  9,  1932 
Wy  .....  Oct.  I,  1930 
~c ......  June  10,  1931 
Ba  .....  Oct.  1, 1930 
D. Do..  Jan.  16,  1932 
rr.  Nov.  1,  1930 
g. Ha..  Jan.  7,  1931 
rol .....  Dee.  13,  1930 
inlca 
inac- 
five 
?  N.D. =  0.02 
"  =  0.02 
"  =  0.007 
"  =  0.01 
"  =  0.01 
"  =  0.03 
=  0.02 
"  =  0.02 
"  =  0.02 
"  =  0.02 
=  0.02 
=  0.03 
"  =  0.02 
"  =  0.009 
"  =  0.03 
"  =  0.005 
Patient 
Ire .... 
Wa ..... 
Mo ..... i 
Zi  ...... 
Ro ..... 
Mah... 
Bar .... 
La ..... 
Mak .... 
Bus  .... 
Cer... 
Tri .... 
Len.., 
Ben... 
Hu .... 
Fe  .... 
Jan.  7,  1931 
Dec.  18,  1930 
Feb.  4,  1932 
Nov.  1,  1930 
Jan.  23,  1932 
"  2,  1932 
"  7,  1931 
Oct.  4,  1930 
"  4,  1930 
"  4,  1930 
Jan.  7,  1931 
Dec.  17,  1930 
Jan.  28,  1932 
"  28,  1932 
"  29,  1932 
"  28,  1932 
¢¢. 
Clinically  N~.  =0.03 
inac- 
tive 
"  "  "  =  0.02 
"  "  "  =  0.02 
"  "  "  =  0.05 
"  "  "  =  0.03 
"  "  "  =  0.02 
"  "  "  =  0.03 
"  "  "  =  0.006 
"  "  "  =  0.009 
"  "  "  =  0.02 
"  "  "  =  0.02 
"  "  "  =  0.04 
"  "  I  "  =0.03 
l 
"  "  "  =  0.03 
"  "  "  =  0.009 
"  "  "  =  0.02 
vals during health and disease.  The findings are presented in Table 
XIV. 
TABLE  XIV 
Antistreptolysin  Titer of Rkeumatic  Subjects before, during and after Attacks  of tke 
Disease 
Patient 
R  ......... 
G ......... 
C ......... 
S ......... 
P ......... 
O ......... 
Good  ~cute  Re- 
__healt]  __tttack cover:__ 
**  0%  o:o3 
0.02  o.oo6 l 
0.03  0.006]  0.02 
0.0031 0.00 
0.004]  0.02 
0.008[  0.02 
 ee ll 
LI  Patien, 
/I 
c¢. 
0.003  Gi ..... 
o.oo811  F  ...... 
II  Ke ..... 
o oo ii w  ..... 
o0041J  ...... 
Good 
healt[ 
¢c. 
N.D. 
u 
"  -  0.02 
"  --  0.03 
Acute  Re- 
_attack  covery__ __ 
0:oo21  o:o  
0.02  ]  0.02 
0.002]  0.002 
0.005 I 
0.004[ 
R~- 
d~- 
cence 
¢¢. 
.0008 
Table XIV shows that in most patients the titer of antistreptolysin 
became high during the attack of acute rheumatism, returned to a 
normal  level  in  quiescence  and  rose  again  during  recrudescence. 
Patient S. had chronic suppurative otitis during the period of apparent ALVIN  I  ~.  COBURN  AND  RUTH  H.  PAULI  671 
recovery; his titer changed only slightly.  Patient Ker. had three severe 
rheumatic attacks within 8 months, and during the 3rd the titer was 
found to be extremely high.  Patient F. with rheumatic heart disease 
developed pericarditis.  Hemolytic streptococcus was not recovered 
from the throat; precipitins to the protein fraction of this organism 
were not detected in  the  serum.  This was  the  only normal  anti- 
streptolysin fiter obtained in this series of patients with frank carditis. 
TABLE  XV 
Antistreptolysin  Titer during  the  Three Phases  of the Rheumatic  Attack 
Patient  Date  Clinical condition  Titer 
R. 
A. 
H. 
W. 
Apr.  13 
"  18 
May  5 
Jan.  9 
Feb.  6 
"  11 
Dec. 10 
Mar. 12 
"  17 
"  31 
Apr.  5 
Oct.  1 
June  1 
Mar. 25 
"  31 
Apr.  5 
"  8 
"  13 
MaY  5 
Hemolytic streptococcus  pharyngitis 
Quiescent interval 
Cardifis and nephritis 
Hemolytic streptococcus  pharyngitis 
End of quiescent interval 
Fever, arthritis, cardifis 
Rheumatism  inactive 
Hemolytic streptococcus  pharyngitis 
Quiescent interval 
Onset of attack 
Severe polyarthritls and carditis 
Rheumatism  inactive 
Hemolytic streptococcus  pharyngitis 
Quiescent interval 
Fever, malaise, leucocytosis 
Erythema  marginatum 
Polyarthritls 
6c. 
N.D.  =  0.003 
"  =  0.003 
"  =  0.002 
"  =  0.04 
"  =  0.02 
"  =  0.005 
"  =  0.02 
"  =  0.02 
"  =  0.005 
"  =  0.004 
"  =  0.02 
"  =  0.03 
"  =  0.04 
"  ~  0.03 
"  =  0.03 
"  =  0.008 
"  =  0.004 
"  =  0.004 
Another study was made to determine the exact time relationship 
between the rise in antistreptolysin and the appearance of rheumatic 
manifestations.  The findings are presented in Table XV. 
Table XV illustrates first, the findings in rheumatic patients with a 
high titer and second, the findings in patients with a normal titer of 
antistreptolysin at the onset of hemolytic streptococcus infection.  In 
the former,  Patient R.,  there was little  change in titer.  The slight 
rise  occurred on the  day that  carditis manifested itself  (sudden de- 
velopment of prolonged conduction time P-R interval equal to 0.22 672  STREP.  HEMOLYTICUS  AND  RHEUMATIC  FEVER.  III 
seconds).  In the latter, Patients A. and H., the titer rose sharply on 
the day of onset of the rheumatic attack.  In Patient W., under close 
observation,  the  quiescent interval ended on April  6.  On  April  8, 
vague symptoms and fever with leucocytosis were noted.  The titer 
rose from an N.D. of 0.03 CC. on April 5 to an I~I.D. of 0.008  cc. on April 
8.  During the following days the titer of antistreptolysin reached a 
plateau level of an N.D. of 0.004  CC., and the patient developed  skin 
and joint manifestations of active rheumatism.  6 
Finally, a  study was made to compare the relationship of the de- 
velopment of antistreptolysin with the appearance of the precipitins 
in the rheumatic subject and in the non-rheumatic individual.  For 
this purpose the sera of patients recovering from hemolytic streptococ- 
cus infection were tested at frequent intervals.  The findings are pre- 
sented in Table XVI. 
From Table XVI it is seen that in the sera of two non-rheumatic 
subjects, Ho. and O'H., with hemolytic  streptococcus infection, precipi- 
tins were not  detected.  Each of these individuals developed anti- 
streptolysin.  This titer remained at a high level for a period of weeks. 
The findings in these two individuals are representative.  In the ma- 
jority of non-rheumatic subjects recovering from hemolytic streptococ- 
cus infection, although precipitins were either weak or absent, anti- 
streptolysin appeared in  titer which remained at a  constantly high 
level until after recovery.  This was shown in the small group of pa- 
tients  convalescing  from  scarlet  fever.  Precipitin  reactions  were 
strong in only the one individual, who developed rheumatic fever; the 
antistreptolysin titer was high, however, in each instance. 
In contrast, in most patients with acute rheumatism, both of these 
antibodies were detected.  In nearly every instance the antistreptoly- 
s Two  exceptions have been noted.  Patient  Au., a rheumatic subject, con- 
tracted hemolytic streptococcus pharyngitis but  failed to develop any clinical 
evidence of rheumatic fever.  The titer of antistrept01ysin remained N.D. =0.02 
cc.  for  1  month.  Patient  Le.  on the  7th day after  hemolytic streptococcus 
pharyngitis developed  acute rheumatism and infectious  mononucleosis.  The anti- 
streptolysin titer remained constant, N.D. = 0.02 cC. throughout the illness.  Dr. 
John Paul of New Haven studied samples of this patient's  serum and detected 
the development of an heterophile antibody.  Agglutinins to  sheep red blood 
cells appeared in titer 1:128 during the 2nd week of the illness. ALVIN  F.  COBURN  AND  RUTH  H.  PAULI  673 
TABLE  XVI 
A Comparison of Precipitin Formation with the Development of Antistreptolysin 
Patient  Time  Clinical condition 
Anfistreptolysin 
titer 
*Precipitln reac- 
tion fraction 
CITD  C17K 
A.  Non-rheumatic subjects 
Ho. 
O'H. 
1st  wk. 
2nd 
3rd 
4th 
$th 
2nd 
3rd 
4th 
6th 
Hemolytic streptococcus  pharyngitis 
"  "  pansinusitis 
Subsiding sinusitis 
Convalescence 
Recovery 
Hemolytic streptococcus  pneumonia 
Convalescence 
Recovery 
co. 
U.D.  =  0.01 
"  =  0.0008 
"  =  0.001 
"  =  0.003 
"  =  0.006 
"  =  0.004 
"  =  0.003 
"  =  0.003 
"  =  0.003 
_  D 
M 
m 
m 
m 
m  u 
B.  Rheumatic subjects 
Maz. 
Wil. 
Man. 
2nd 
3rd 
4th 
5th 
6th 
7th 
8th 
9th 
12th 
1st 
2nd 
3rd 
4th 
5th 
t6th 
8th 
1st 
2nd 
3rd 
Acute  rheumatic  fever 
tt  it  . 
tc  ct  . 
Subsiding  "  " 
(¢  ~c  c( 
Acute  "  " 
c(  (c  i( 
(c  .  tc 
Subsiding  "  " 
Hemolytic streptococcus pharyngitis 
Rheumatic recrudescence 
Acute rheumatic fever 
Death 
N.D. 
(4 
tc 
(¢ 
c¢. 
=  0.003 
=  0.003 
=  0.003 
=  0.003 
=  0.003 
=  0.004 
=  0.004 
=  0.004 
=  0.004 
=  0.007 
=  0.007 
=  0.006 
=  0.007 
=  0.008 
=  0.02 
=  0.007 
=  0.002 
=  0.002 
=  0.002 
+  + 
+  + 
++  ++ 
+  + 
+ 
+  + 
Serum cloudy 
+ 
*  Precipitin  determinations  represent  overnight  readings,  uncentrifuged. 
1" The  sudden  fall in the  fiter of antistreptolysin  has been  observed  in other  patients  at 
the onset of acute hemolytic  streptococcus  infection. 
sin titer remained normal during the infection and the quiescent in- 
terval, but rose at the onset of the rheumatic attack.  It reached a 
plateau level during the 1st week of rheumatism and did not increase 
after this.  On the other hand, precipitins which were not detected 674  STREP.  HEMOLYTICUS  AND  RHEUMATIC  FEVER.  III 
during the period of infection nor in the quiescent interval, appeared 
in weak concentration during the first few days of rheumatism.  As 
the attack increased in severity, the precipitin reaction became more 
marked.  With a certain degree of fluctuation, there was a parallelism 
between increasing intensity of the disease and the development of 
strong precipitins.  Patient Maz.  during the 3rd and 4th weeks ap- 
peared extremely ill, and precipitins were most marked in this period, 
but  the antistreptolysin titer  did not rise.  In  the  case  of Patient 
Man. with fulminating rheumatism, the antistreptolysin titer remained 
at a constant level and the precipitins increased in strength until the 
day  of  death.  In  those  individuals who  recovered,  demonstrable 
precipitins disappeared rapidly, but the titer of antistreptolysin per- 
sisted at a high level for a long period of time. 
Summary of Antistreptolysin Determinations 
In the normal individual in good health, the titer of antistreptolysin 
is of such a  degree that 0.01  cc.  of serum neutralizes  2½  minimal 
hemolytic doses of yeast extract streptolysin.  The antistreptolysin 
fiter  of  patients  convalescing from  diseases  other  than  hemolytic 
streptococcus infection is approximately normal.  The antistreptoly- 
sin titer of patients during the acute stage of illness with hemolytic 
streptococcus infection is  also  approximately normal.  In  patients 
convalescing from  infection with hemolytic streptococcus, the N.D. 
is approximately 0.005  cc.  in most instances.  The antistreptolysin 
fiter of rheumatic subjects with inactive disease is usually normal or 
slightly elevated.  The  antistreptolysin titer  of inactive rheumatic 
subjects tested after non-specific stimulation with an heterologous an- 
tigen either remains normal or falls to normal.  In each  rheumatic 
subject during an attack, following hemolytic streptococcus pharyn- 
gitis, the ~1.I). is approximately 0.005  cc.  Likewise in each patient 
with acute rheumatism from whose throat hemolytic streptococcus 
was not recovered at the onset of the attack, the N.D. is also approxi- 
mately 0.005  cc.  Furthermore, in patients with acute rheumatism 
denying previous respiratory infection, the N.D. is also approximately 
0.005 cc.  The antistreptolysin titer falls slowly to normal during re- 
covery and rises in each instance of recrudescence to an 1~1.I). of 0.005 
cc.  The antistreptolysin titer remains normal in the rheumatic sub- ALVII~  ]~.  COBURN  AND  RUTH  H.  PAULI  675 
ject during the first two phases, the period of infection and the quies- 
cent interval, and  rises  precipitously just before the appearance of 
rheumatic manifestations.  Unlike  the  development of  precipitins, 
the antistreptolysin titer reaches its high level during the 1st week of 
the rheumatic attack and maintains this constantly, irrespective  of 
the patient's condition.  Finally, the presence of antistreptolysin in 
titer of such a degree that 0.005 cc. of the patient's serum neutralizes 
2½ minimal hemolytic doses of yeast extract streptolysin, is considered 
a  specific indication of infection with hemolytic streptococcus.  The 
constant finding of this high titer of antistreptolysin in the serum of 
patients with acute rheumatic fever is strong evidence that the rheu- 
matic attack has been initiated by Streptococcus hemolyticus.  There 
is a  close relationship between the time of appearance of this anti- 
body in the circulation and the manifestations of activity of the rheu- 
matic process. 
SUMMARY 
In the first two papers findings were presented which point to a 
close relationship between the incidence of rheumatic fever and the 
distribution of Streptococcus hemolyticus.  The  fact was emphasized 
that in the rheumatic subject a  recrudescence of the disease process 
is usually preceded by pharyngeal infection with hemolytic strepto- 
cocci.  These organisms conspicuous in  the throat flora during the 
period of infection preliminary to an attack of acute rheumatism fell 
into six antigenic groups and produced toxins which in 70 per cent 
were neutralized by a  monovalent streptococcus antiserum.  In the 
present study, four series of observations have been presented, demon- 
strating the development Of immune bodies to hemolytic streptococcus 
during the course of rheumatic fever.  The agglutination and comple- 
ment fixation reactions of sera from patients with acute rheumatism 
suggest recent infection with streptococcus.  Precipitin tests indicate 
that at the time of appearance of the rheumatic attack,  individuals 
develop, in their blood, precipitins to the protein fractions of hemolytic 
streptococcus.  That  these precipitins may not be  entirely specific 
is recognized from their cross-reactions with antigens of chemically 
related organisms.  The studies made in association with E. W. Todd 
of England have demonstrated that at the onset of an attack of acute 676  STREP.  HEMOLYTICUS AND  RHEII~ATIC  FEVER.  III 
rheumatism, there occurs in each instance a rise in the antistreptolysin 
titer  of the patient's  serum.  This titer  is  much higher  than  that 
observed in normal subjects or in patients with bacterial  infection 
other than  hemolytic streptococcus.  This  presence of antistreptol- 
ysin with an N.D. of 0.005 cc. is considered strong evidence of recent 
infection by hemolytic streptococcus.  In conclusion, the relationship 
between the incidence of hemolytic streptococcus and the geographical 
distribution of rheumatic fever, the relationship between the recrudes- 
cence in the rheumatic subject and infection of the throat with hemo- 
lytic streptococcus, the development of immune bodies for hemolytic 
streptococcus at the onset of the rheumatic attack and the apparently 
specific relationship of antistreptolysin formation to  infection with 
hemolytic streptococcus,--together this combined evidence indicates 
that the infectious agent initiating the rheumatic process is Strepto- 
coccus hemolyticus. 
These studies have been conducted  under the direction  of Dr. Alphonse 
R. Dochez, with the advice of Dr.  Michael  Heidelberger, with  the 
nursing care of Miss Lucille Miller and Miss Mary Kelly and, finally, 
with the generous assistance of Dr. E. W. Todd.  For their kind help 
the authors wish to express their appreciation. 
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